Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Kidney Cancer

Drugs for Kidney Cancer (Renal-Cell Carcinoma)

One Race at a Time: How a Cancer Diagnosis Strengthened My Life as an Accomplished Triathlete
By 2012, Mike Morris has completed a triathlon in all 50 states. In 2015, he hiked Mt. Kilimanjaro. Then, a CT scan showed that he had metastatic renal-cell carcinoma that spread to his brain. Read More ›

Keytruda FDA Approved for Adjuvant Treatment of Kidney Cancer
In November 2021, the FDA approved a new indication for the immunotherapy Keytruda (pembrolizumab) for adjuvant treatment (after surgery) of patients with renal-cell carcinoma that is at intermediate-high or high risk for recurrence. Read More ›

Immunotherapy After Surgery May Be a New Standard of Care for Patients with Advanced Kidney Cancer

A Review of Kidney Cancer and Encouragement Toward Empowered Survivorship
Carly Gerretsen, DNP, RN, FNP-C, RNFA, provides an overview of kidney cancer, explaining the various stages of a kidney cancer diagnosis, symptoms, treatment options, caregiver’s assistance, and stress management advice. Read More ›

A Guide to Kidney Cancer for Survivors and Caregivers: Empowerment Through Knowledge, Communication, and Self-Care
Carly Gerretsen, DNP, RN, FNP-C, RNFA, offers an overview of kidney cancer and the treatment options, advising how to take control of controllable factors and take care of yourself. Read More ›

March Is Kidney Cancer Awareness Month
View this slideshow to learn important facts about kidney cancer, including statistics, causes and symptoms. Read More ›

Opdivo plus Yervoy First Immunotherapy Regimen for Initial Treatment of Kidney Cancer
The use of Opdivo with Yervoy is the first immunotherapy combination therapy approved by the FDA for patients with kidney cancer. Read More ›

A Second Chance at Life: Kidney Cancer Was My Wake-Up Call to Healthier Living
Richard J. Smith tells his experience with kidney cancer, which led him to lose weight, be more active, and live a healthy life. Read More ›

The Gifts of Cancer
After several weeks of hematuria (blood in the urine), lab tests, a visit to the emergency department, a CT scan, and a biopsy, Robert Aron, PhD, sat in the urologist’s office awaiting his results. Read More ›

Page 1 of 2